差價合約是複雜的工具，並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損。您應該考慮自己是否了解差價合約的運作方式，以及您是否有能力承擔損失資金的高風險。
Capital Com Australia Pty Ltd 澳大利亞（受 ASIC 監管） Capital Com UK Limited 由金融行為監管局 (FCA) 授權和監管 Capital Com SV Investments Limited 塞浦路斯/歐盟（受 CYSEC 監管） Сlosed Joint Stock Company «FinTech Solutions» （受 NBRB 監管） Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd 塞舌爾（受 FSA 監管） Capital Com Online Investments Ltd (Regulated by SCB) 我們的全球辦事處

掃碼下載 iOS 和安卓 APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Also you can contact us: call +44 20 8089 7893 support@capital.com

交易 Maravai Life Sciences Inc. - MRVI CFD

15.36
1.65%
0.22
低: 15.15
高: 15.55
Market Trading Hours* (UTC) Opens on Friday at 14:30

Mon - Fri: 14:30 - 21:00

  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.22
多頭倉位隔夜費用

Long position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.030779%
空頭倉位隔夜費用

Short position overnight fee

Margin. Your investment $1,000.00
隔夜費用 -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00
前往平台
-0.013666%
隔夜費時間 22:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 15.11
開盤價* 15.54
1 年變化* -47.76%
日範圍* 15.15 - 15.55
52 周範圍 12.16-41.82
平均交易量（10 天） 993.80K
平均交易量（3 個月） 39.51M
市值 3.86B
市盈率 6.45
流通股 255.21M
收入 906.73M
EPS 2.35
股息（收益率 %） N/A
貝塔 -100.00K
下一個財報發布日期 Feb 22, 2023

所有數據都是由Refinitiv提供的， 除了標有星號的數據， 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開 高 低
Feb 2, 2023 15.36 0.03 0.20% 15.33 15.57 15.07
Feb 1, 2023 15.11 0.58 3.99% 14.53 15.30 14.31
Jan 31, 2023 14.54 0.11 0.76% 14.43 14.63 14.24
Jan 30, 2023 14.32 0.05 0.35% 14.27 14.41 14.03
Jan 27, 2023 14.40 0.70 5.11% 13.70 14.72 13.64
Jan 26, 2023 13.87 0.35 2.59% 13.52 14.15 13.52
Jan 25, 2023 13.85 0.51 3.82% 13.34 13.85 13.02
Jan 24, 2023 13.50 -0.40 -2.88% 13.90 14.33 13.39
Jan 23, 2023 14.46 0.52 3.73% 13.94 14.63 13.67
Jan 20, 2023 14.02 0.21 1.52% 13.81 14.03 13.65
Jan 19, 2023 13.95 0.25 1.82% 13.70 13.99 13.49
Jan 18, 2023 13.96 0.19 1.38% 13.77 14.48 13.51
Jan 17, 2023 13.74 0.27 2.00% 13.47 13.85 13.38
Jan 13, 2023 13.72 0.21 1.55% 13.51 13.82 13.39
Jan 12, 2023 13.71 0.18 1.33% 13.53 14.08 13.26
Jan 11, 2023 13.99 0.42 3.10% 13.57 14.02 13.39
Jan 10, 2023 13.57 0.90 7.10% 12.67 13.87 12.67
Jan 9, 2023 12.94 -0.20 -1.52% 13.14 13.38 12.86
Jan 6, 2023 13.13 0.10 0.77% 13.03 13.41 13.00
Jan 5, 2023 13.15 0.23 1.78% 12.92 13.43 12.10

Maravai Life Sciences Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • 年度
  • 每季度
2018 2019 2020 2021
總收入 123.833 143.14 284.098 799.24
收入 123.833 143.14 284.098 799.24
收入成本，共計 60.765 66.849 79.649 140.561
毛利 63.068 76.291 204.449 658.679
總營業費用 113.019 119.152 171.788 244.595
銷售/一般/行政費用，總計 33.194 40.354 94.245 100.064
研究與開發 4.499 3.627 1.704 9.319
Depreciation / Amortization 8 8 7.6 5.9
異常費用（收入） 5.622 0 -11.41 -11.249
Other Operating Expenses, Total 0.939 0.322 0 0
營業收入 10.814 23.988 112.31 554.645
利息收入（費用），非經營淨值 -27.399 -29.959 -30.74 -30.26
其他，淨值 0.087 0.118 0.126 6.38
稅前淨收入 -16.498 -5.853 81.696 530.765
稅後淨收入 -16.915 -5.201 78.816 469.25
少數股東權益 4.446 2.4 13.342 -287.213
未計算非常項目前的淨收益 -12.469 -2.801 92.158 182.037
淨收入 -12.469 -2.801 92.158 182.037
Total Adjustments to Net Income -5.259 -5.68 -15.27
普通股股東可獲收益 (不含非經常性項目) -17.728 -8.481 76.888 182.037
普通股股東可獲收益 (含非經常性項目) -17.728 -8.481 76.888 182.037
攤薄淨收入 -17.728 -8.481 76.888 402.356
攤薄後加權平均股 257.621 257.621 257.621 257.803
扣除特別項目的每股攤薄盈利 -0.06881 -0.03292 0.29845 1.56071
Dividends per Share - Common Stock Primary Issue 0 0
每股正常攤薄盈利 -0.05463 -0.03292 0.27165 1.52746
攤薄調整 220.319
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
總收入 148.211 217.775 204.81 228.444 244.293
收入 148.211 217.775 204.81 228.444 244.293
收入成本，共計 31.391 37.513 32.047 40.633 40.032
毛利 116.82 180.262 172.763 187.811 204.261
總營業費用 57.022 63.53 47.937 77.359 77.135
銷售/一般/行政費用，總計 21.571 24.085 25.189 27.553 32.4
研究與開發 2.16 0.032 0.45 8.573 3.695
Depreciation / Amortization 1.9 1.9 1.5 0.6 0.8
異常費用（收入） 0 0 -11.249 0 0.208
營業收入 91.189 154.245 156.873 151.085 167.158
利息收入（費用），非經營淨值 -7.904 -8.512 -8.545 -4.433 -2.664
其他，淨值 5.889 -0.003 3.324 -2.83 2.347
稅前淨收入 89.174 145.73 151.652 143.822 166.841
稅後淨收入 75.465 134.344 132.81 126.244 146.86
少數股東權益 -52.363 -85.269 -78.536 -70.803 -79.998
未計算非常項目前的淨收益 23.102 49.075 54.274 55.441 66.862
淨收入 23.102 49.075 54.274 55.441 66.862
普通股股東可獲收益 (不含非經常性項目) 23.102 49.075 54.274 55.441 66.862
普通股股東可獲收益 (含非經常性項目) 23.102 49.075 54.274 55.441 66.862
攤薄淨收入 23.102 49.094 115.148 109.642 127.963
攤薄後加權平均股 96.673 112.28 258.028 257.815 255.287
扣除特別項目的每股攤薄盈利 0.23897 0.43724 0.44626 0.42527 0.50125
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 0.24698 0.44554 0.40691 0.42793 0.48959
Total Adjustments to Net Income 0 0
攤薄調整 0.019 60.874 54.201 61.101
Other Operating Expenses, Total 0
  • 年度
  • 每季度
2018 2019 2020 2021
流動資産總額 53.802 60.552 331.598 740.039
現金和短期投資 21.866 24.7 236.184 551.272
Cash 21.866 24.7 236.184 551.272
應收賬款總額，淨額 15.991 18.83 51.218 117.512
Accounts Receivable - Trade, Net 15.991 18.83 51.218 117.512
Total Inventory 14.308 14.202 33.301 51.557
Prepaid Expenses 1.637 2.82 10.895 19.698
Total Assets 539.676 577.796 1270.69 1918.28
Property/Plant/Equipment, Total - Net 42.578 94.311 101.305 95.427
Property/Plant/Equipment, Total - Gross 31.492 102.41 111.952 107.959
Accumulated Depreciation, Total -4.289 -8.099 -10.647 -12.532
Goodwill, Net 224.275 224.275 224.275 152.766
Intangibles, Net 218.127 197.853 177.656 117.571
Other Long Term Assets, Total 0.894 0.805 435.857 812.473
Total Current Liabilities 35.919 29.562 130.778 93.777
Accounts Payable 3.604 7.478 8.171 8.154
Accrued Expenses 11.147 16.515 29.014 29.34
Notes Payable/Short Term Debt 0 0 0 0
Current Port. of LT Debt/Capital Leases 2.5 2.5 6 6
Other Current Liabilities, Total 18.668 3.069 87.593 50.283
Total Liabilities 395.271 436.4 1182.18 1602.78
Total Long Term Debt 337.389 387.702 584.781 524.591
Long Term Debt 335.55 334.783 528.614 524.591
Capital Lease Obligations 1.839 52.919 56.167 0
Deferred Income Tax 15.856 14.697 8.609 0
Minority Interest 3.611 3.231 66.235 229.862
Other Liabilities, Total 2.496 1.208 391.777 754.547
Total Equity 144.405 141.396 88.511 315.499
Common Stock 182.809 183.91 2.576 2.552
Retained Earnings (Accumulated Deficit) -38.237 -42.381 0.854 184.561
Other Equity, Total -0.167 -0.133 -0.044 0
Total Liabilities & Shareholders’ Equity 539.676 577.796 1270.69 1918.28
Total Common Shares Outstanding 257.621 257.621 257.621 255.157
Additional Paid-In Capital 85.125 128.386
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
流動資産總額 425.543 644.491 687.478 740.039 619.135
現金和短期投資 247.675 374.71 547.898 551.272 431.469
Cash 247.675 374.71 547.898 551.272 431.469
應收賬款總額，淨額 122.821 83.534 65.939 117.512 120.355
Accounts Receivable - Trade, Net 122.821 83.534 65.939 117.512 120.355
Total Inventory 47.129 47.781 56.246 51.557 51.409
Prepaid Expenses 7.918 13.432 17.395 19.698 15.902
Total Assets 1351.77 1601.25 1894.68 1918.28 2043.23
Property/Plant/Equipment, Total - Net 105.133 104.751 108.322 46.332 47.702
Goodwill, Net 224.275 152.766 152.766 152.766 283.535
Intangibles, Net 172.616 125.116 121.225 117.571 235.405
Other Long Term Assets, Total 424.201 574.123 824.892 861.568 857.453
Total Current Liabilities 165.252 164.773 114.352 93.777 86.675
Accounts Payable 9.806 11.704 8.917 8.154 10.384
Accrued Expenses 28.973 17.711 30.248 29.34 32.411
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6 7.083 7.174 6 5.44
Other Current Liabilities, Total 120.473 128.275 68.013 50.283 38.44
Total Liabilities 1239.16 1407.33 1592.05 1602.78 1660.67
Total Long Term Debt 583.517 582.209 580.908 524.591 524.499
Long Term Debt 527.593 526.583 525.584 524.591 524.499
Capital Lease Obligations 55.924 55.626 55.324 0
Deferred Income Tax 8.571 0 0 0
Minority Interest 97.145 139.22 150.979 229.862 271.743
Other Liabilities, Total 384.672 521.124 745.807 754.547 777.754
Total Equity 112.611 193.921 302.637 315.499 382.559
Common Stock 2.576 2.576 2.576 2.552 2.552
Additional Paid-In Capital 85.976 118.208 172.611 128.386 128.584
Retained Earnings (Accumulated Deficit) 24.101 73.176 127.45 184.561 251.423
Other Equity, Total -0.042 -0.039 0 0
Total Liabilities & Shareholders’ Equity 1351.77 1601.25 1894.68 1918.28 2043.23
Total Common Shares Outstanding 257.621 257.66 257.66 255.157 255.159
Other Current Assets, Total 125.034
  • 年度
  • 每季度
2018 2019 2020 2021
淨收入/起跑線 -16.915 -5.201 78.816 469.25
經營活動産生的現金 -0.186 24.115 152.187 368.57
經營活動産生的現金 2.225 3.81 5.517 6.413
Amortization 20.122 20.274 20.32 18.339
Deferred Taxes 0.317 -1.159 -5.464 46.904
非現金物品 9.906 4.101 17.105 4.295
Cash Taxes Paid -0.097 -0.802 5.006 22.473
已付現金利息 25.678 28.728 28.916 27.234
營運資金的變化 -15.841 2.29 35.893 -176.631
投資活動産生的現金 -3.451 -17.148 6.068 105.655
資本支出 -3.611 -17.148 -28.432 -14.85
其他投資現金流量項目，總計 0.16 0 34.5 120.505
融資活動産生的現金 -9.167 -4.167 53.212 -159.049
融資現金流項目 -64.595 -1.527 -444.983 -154.758
債務的發行（退還），淨額 55.428 -2.64 196.924 -6
外彙效應 -0.069 0.034 0.017 -0.088
現金淨變化 -12.873 2.834 211.484 315.088
股票的發行（報廢），淨額 301.271 1.709
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 75.465 210.196 343.006 469.25 146.86
Cash From Operating Activities 38.326 204.297 310.403 368.57 162.304
Cash From Operating Activities 1.256 4.151 6.623 6.413 1.855
Amortization 5.041 10.081 14.685 18.339 5.527
Deferred Taxes 11.76 18.211 29.438 46.904 13.217
Non-Cash Items -0.876 -0.133 -11.033 4.295 3.083
Cash Taxes Paid 2.725 9.087 -16.569 22.473 0.914
Cash Interest Paid 7.219 15.547 23.03 27.234 1.373
Changes in Working Capital -54.32 -38.209 -72.316 -176.631 -8.238
Cash From Investing Activities -2.784 -7.234 111.317 105.655 -241.584
Capital Expenditures -3.332 -7.782 -9.188 -14.85 -241.584
Other Investing Cash Flow Items, Total 0.548 0.548 120.505 120.505 0
Cash From Financing Activities -24.058 -58.55 -110.051 -159.049 -40.523
Financing Cash Flow Items -23.128 -56.203 -106.298 -154.758 -39.889
Issuance (Retirement) of Stock, Net 0.57 1.018 1.329 1.709 0.726
Issuance (Retirement) of Debt, Net -1.5 -3.365 -5.082 -6 -1.36
Foreign Exchange Effects 0.007 0.013 0.045 -0.088 0
Net Change in Cash 11.491 138.526 311.714 315.088 -119.803
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
GTCR Golder Rauner, LLC Private Equity 16.4825 21681033 0 2022-12-31 LOW
MFS Investment Management Investment Advisor/Hedge Fund 10.5967 13938892 1459685 2022-09-30 LOW
Select Equity Group, L.P. Investment Advisor/Hedge Fund 8.759 11521575 -4929263 2022-10-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.7487 10192617 -220435 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 3.8298 5037672 -45681 2022-09-30 LOW
Ownership Capital Investment Advisor 3.1088 4089326 -302724 2022-09-30 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 2.9636 3898351 1501611 2022-09-30 LOW
ClearBridge Investments, LLC Investment Advisor/Hedge Fund 2.2622 2975735 267860 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 2.2546 2965668 68095 2022-09-30 LOW
Thrivent Asset Management, LLC Investment Advisor 1.946 2559746 2559746 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 1.9182 2523185 -1037590 2022-09-30 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 1.579 2077036 1538680 2022-09-30 HIGH
Citi Investment Research (US) Research Firm 1.4941 1965345 517954 2022-09-30 LOW
Citadel Advisors LLC Hedge Fund 1.3868 1824165 1687956 2022-09-30 HIGH
Millennium Management LLC Hedge Fund 1.3656 1796274 1687021 2022-09-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.3342 1754976 6088 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.2681 1668086 38486 2022-09-30 LOW
Alyeska Investment Group, L.P. Hedge Fund 1.2236 1609572 586041 2022-09-30 HIGH
Renaissance Technologies LLC Hedge Fund 1.1576 1522700 -352300 2022-09-30 HIGH
Invesco Advisers, Inc. Investment Advisor 1.1091 1458875 29406 2022-09-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+485000+

Traders

65000+

Active clients monthly

$48000000+

Monthly investing volume

$28000000+

Withdrawn each month

差價合約交易計算器

計算您的假設損益

交易佣金
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
槓桿
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模（槓桿 x 投資）：
打開

關閉

做空 做多
過往表現並非未來業績的可靠指標
盈利/虧損
Industry: Bio Therapeutic Drugs

10770 Wateridge Circle Suite 200
Suite 200
SAN DIEGO
CALIFORNIA 92121
US

收入報表

  • Annual
  • Quarterly

人們也觀看

Oil - Crude

76.04 Price
-0.130% 1D Chg, %
多頭倉位隔夜費用 -0.0220%
空頭倉位隔夜費用 0.0066%
隔夜費時間 22:00 (UTC)
價差 0.03

US100

12,596.80 Price
-0.180% 1D Chg, %
多頭倉位隔夜費用 -0.0182%
空頭倉位隔夜費用 0.0070%
隔夜費時間 22:00 (UTC)
價差 1.8

BTC/USD

23,468.80 Price
-0.040% 1D Chg, %
多頭倉位隔夜費用 -0.0500%
空頭倉位隔夜費用 0.0140%
隔夜費時間 22:00 (UTC)
價差 60.00

XRP/USD

0.42 Price
+0.990% 1D Chg, %
多頭倉位隔夜費用 -0.0500%
空頭倉位隔夜費用 0.0140%
隔夜費時間 22:00 (UTC)
價差 0.00337

還在尋找值得信賴的經紀商？

加入全球 485.000 多名交易者，選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易